Quantcast

Latest Anti-diabetic drug Stories

2011-09-05 11:23:24

Research offers hope for better treatments for diabetes patients In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. The finding paves the way for the development of anti-diabetic therapeutics with minimal adverse side effects plaguing currently available drugs such as Avandia (rosiglitazone), scheduled to be removed from...

2011-06-27 17:30:00

MOUNTAIN VIEW, Calif., June 27, 2011 /PRNewswire/ -- ChemoCentryx, Inc. today announced that CCX140, the Company's novel, orally active CCR2 antagonist successfully met its primary endpoint of safety and tolerability and demonstrated clinical efficacy in a Phase II study in patients with type 2 diabetes on stable doses of metformin. These data were presented today in San Diego at the 71st Annual Scientific Session of the American Diabetes Association in an oral presentation entitled "Oral...

2011-06-20 08:00:00

RIDGEFIELD, Conn. and INDIANAPOLIS, June 20, 2011 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) will present the latest data from their diabetes portfolio at the 71st American Diabetes Association (ADA) Scientific Sessions in San Diego on June 24-28. Study results evaluating the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, as well as the investigational sodium glucose cotransporter-2 (SGLT-2) inhibitor BI-10773, will be featured among the 27...

2011-05-02 16:23:32

University of Cincinnati (UC) researchers have determined why a certain class of diabetes drugs leads to weight gain and have found that the molecular system involved (PPAR-ÃŽ³ found in the brain) is also triggered by consumption of high-fat foods. The study could lead to the modification of existing diabetes therapies and even dietary recommendations to limit the action of this nuclear receptor in the brain. The research, led by Randy Seeley, PhD, UC professor and Donald C....

2011-02-23 13:31:31

Analysis highlights cardiovascular risk of fluid retention New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration (FDA) if the cardiovascular effects of fluid retention had been better understood. Fluid retention may explain the increased risk of heart attacks and strokes of medications such as Vioxx®, Bextra®, and...

d08251b930a26c7c64edf09b539d2d1a1
2011-01-14 10:20:00

A 5-year study from Australia concludes that increasing your daily step count not only wards off obesity but reduces the risk of insulin resistance and diabetes complications. Several studies have shown that increasing physical activity reduces body mass index and insulin resistance - an early stage in the development of diabetes. This is the first study to estimate the effects of long-term changes in daily step count on insulin sensitivity. The nationwide study undertaken in Australia...

2010-11-22 06:30:00

SAN DIEGO, Nov. 22, 2010 /PRNewswire/ -- Profil(TM) Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials. "Assessing cardiac safety is a critical early objective for the evaluation of new drugs, particularly in compounds for the treatment of diabetes,"...

2010-11-03 00:00:35

Treatment approaches evolve, focus on better ways to improve patient outcomes Lansdale, PA (PRWEB) November 2, 2010 For the 24 million Americans living with diabetes and the 57 million more who are at risk of developing type 2 diabetes, treatment approaches continue to evolve as new research focuses on better ways to improve patient outcomes. During American Diabetes Month in November, Hayes, Inc. (http://www.hayesinc.com) urges clinicians and patients to learn as much as possible about new...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.